Philip Charles Hoffman to Organoplatinum Compounds
This is a "connection" page, showing publications Philip Charles Hoffman has written about Organoplatinum Compounds.
Connection Strength
0.108
-
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Ann Oncol. 2004 Jun; 15(6):915-20.
Score: 0.060
-
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest. Invest New Drugs. 2001; 19(4):303-10.
Score: 0.048